DK2800575T3 - Behandling af subarachnoidalblødning og iskæmi - Google Patents
Behandling af subarachnoidalblødning og iskæmi Download PDFInfo
- Publication number
- DK2800575T3 DK2800575T3 DK12857611.3T DK12857611T DK2800575T3 DK 2800575 T3 DK2800575 T3 DK 2800575T3 DK 12857611 T DK12857611 T DK 12857611T DK 2800575 T3 DK2800575 T3 DK 2800575T3
- Authority
- DK
- Denmark
- Prior art keywords
- subarachnoidal
- injury
- blood
- treatment
- subarachnoidal blood
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Biotechnology (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161570264P | 2011-12-13 | 2011-12-13 | |
CA2762338A CA2762338C (en) | 2011-12-13 | 2011-12-15 | Therapy for subarachnoid hemorrhage and ischemia |
US201261617001P | 2012-03-28 | 2012-03-28 | |
PCT/IB2012/057259 WO2013088382A1 (en) | 2011-12-13 | 2012-12-13 | Therapy for subarachnoid hemorrhage and ischemia |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2800575T3 true DK2800575T3 (da) | 2019-07-01 |
Family
ID=51228598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12857611.3T DK2800575T3 (da) | 2011-12-13 | 2012-12-13 | Behandling af subarachnoidalblødning og iskæmi |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP2800575B1 (da) |
JP (3) | JP6279483B2 (da) |
KR (2) | KR102114490B1 (da) |
CN (1) | CN104053448B (da) |
AU (1) | AU2012354072B2 (da) |
DK (1) | DK2800575T3 (da) |
ES (1) | ES2731266T3 (da) |
IL (1) | IL233103B (da) |
MX (1) | MX364562B (da) |
SG (2) | SG10201604676WA (da) |
WO (1) | WO2013088382A1 (da) |
ZA (1) | ZA201404636B (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI1010718A2 (pt) | 2009-06-10 | 2016-03-15 | Nono Inc | sistemas modelo e regimes de tratamento para tratar doença neurológica. |
KR102140169B1 (ko) | 2011-06-24 | 2020-07-31 | 노노 인코포레이티드 | 허혈에 대한 psd-95 억제제와의 조합 요법 |
US9241970B2 (en) | 2011-12-13 | 2016-01-26 | Nono Inc. | Therapy for subarachnoid hemorrhage and ischemia |
US10206973B2 (en) | 2014-05-28 | 2019-02-19 | Nono Inc. | Chloride salt of TAT-NR2B9c |
CN107312071B (zh) * | 2016-04-27 | 2018-11-06 | 拜西欧斯(北京)生物技术有限公司 | 兴奋性神经毒性相关损伤的治疗方法 |
JP2019522675A (ja) * | 2016-04-27 | 2019-08-15 | ▲拝▼西欧斯(北京)生物技▲術▼有限公司 | 興奮製神経毒性に関連した損傷の治療方法 |
CN109985047B (zh) * | 2017-12-29 | 2021-07-27 | 广州市赛普特医药科技股份有限公司 | 5α-雄甾-3β,5,6β-三醇在制备治疗出血性脑卒中药物中的应用 |
CN109009111A (zh) * | 2018-07-16 | 2018-12-18 | 重庆大学 | 低场核磁共振脑出血动态监护仪控制*** |
CN113284126B (zh) * | 2021-06-10 | 2022-06-24 | 安徽省立医院(中国科学技术大学附属第一医院) | 人工神经网络图像分析预测脑积水分流手术疗效的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7510824B2 (en) * | 1999-06-02 | 2009-03-31 | Nono Inc. | Method of screening peptides useful in treating traumatic injury to the brain or spinal cord |
EP1884521A1 (en) * | 2006-07-31 | 2008-02-06 | Xigen S.A. | Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins |
CA2679831C (en) * | 2007-03-02 | 2018-10-02 | Arbor Vita Corporation | Treating stroke and other diseases without inhibiting n-type calcium channels |
BRPI1010718A2 (pt) * | 2009-06-10 | 2016-03-15 | Nono Inc | sistemas modelo e regimes de tratamento para tratar doença neurológica. |
-
2012
- 2012-12-13 KR KR1020147019192A patent/KR102114490B1/ko active IP Right Grant
- 2012-12-13 ES ES12857611T patent/ES2731266T3/es active Active
- 2012-12-13 EP EP12857611.3A patent/EP2800575B1/en active Active
- 2012-12-13 MX MX2014007031A patent/MX364562B/es active IP Right Grant
- 2012-12-13 WO PCT/IB2012/057259 patent/WO2013088382A1/en active Application Filing
- 2012-12-13 AU AU2012354072A patent/AU2012354072B2/en active Active
- 2012-12-13 CN CN201280061924.1A patent/CN104053448B/zh active Active
- 2012-12-13 SG SG10201604676WA patent/SG10201604676WA/en unknown
- 2012-12-13 DK DK12857611.3T patent/DK2800575T3/da active
- 2012-12-13 JP JP2014546717A patent/JP6279483B2/ja active Active
- 2012-12-13 KR KR1020207014227A patent/KR20200057802A/ko not_active Application Discontinuation
- 2012-12-13 SG SG11201403239UA patent/SG11201403239UA/en unknown
-
2014
- 2014-06-12 IL IL233103A patent/IL233103B/en active IP Right Grant
- 2014-06-24 ZA ZA2014/04636A patent/ZA201404636B/en unknown
-
2017
- 2017-11-10 JP JP2017217549A patent/JP6741642B2/ja active Active
-
2020
- 2020-05-15 JP JP2020085748A patent/JP2020128419A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN104053448B (zh) | 2017-04-05 |
KR20200057802A (ko) | 2020-05-26 |
AU2012354072B2 (en) | 2017-04-27 |
WO2013088382A1 (en) | 2013-06-20 |
KR102114490B1 (ko) | 2020-05-25 |
MX2014007031A (es) | 2015-02-20 |
SG11201403239UA (en) | 2014-09-26 |
EP2800575B1 (en) | 2019-05-22 |
AU2012354072A1 (en) | 2014-07-03 |
EP2800575A4 (en) | 2015-09-23 |
JP6741642B2 (ja) | 2020-08-19 |
IL233103B (en) | 2021-03-25 |
KR20140108266A (ko) | 2014-09-05 |
MX364562B (es) | 2019-04-30 |
JP2018052962A (ja) | 2018-04-05 |
ES2731266T3 (es) | 2019-11-14 |
CN104053448A (zh) | 2014-09-17 |
JP2020128419A (ja) | 2020-08-27 |
IL233103A0 (en) | 2014-07-31 |
JP2015501834A (ja) | 2015-01-19 |
SG10201604676WA (en) | 2016-07-28 |
EP2800575A1 (en) | 2014-11-12 |
ZA201404636B (en) | 2015-10-28 |
JP6279483B2 (ja) | 2018-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2800575T3 (da) | Behandling af subarachnoidalblødning og iskæmi | |
DK2882441T3 (da) | Behandling af immunrelaterede og inflammatoriske sygdomme | |
DOP2016000114A (es) | Tratamiento de la osteoartritis y del dolor | |
DK2882496T3 (da) | Behandling og diagnosticering af melanom | |
DK2734128T3 (da) | Kirurgisk hentningsindretning med halvstift udtrækkelig og sammenklappelig kurv | |
BR112013018469A2 (pt) | dispositivos e métodos para tratamento de tecidos | |
DK2688557T3 (da) | Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed | |
DK3295942T3 (da) | Kombinationer omfattende 5-phenoxy-3h-pyrimidin-4-on-derivater og anvendelse heraf til profylakse eller behandling af hiv-infektion | |
BR112014007217A2 (pt) | método e dispositivo de fixação cirúrgica | |
DK2774616T3 (da) | Anvendelse af roseburia i behandling og forebyggelse af fedmerelaterede sygdomme | |
BR112013013684A2 (pt) | tratamento das condiçóes mediadas por jak-2 | |
DK2806892T3 (da) | Kombineret terapeutisk anvendelse af antistoffer og endoglycosidaser | |
DK3358011T3 (da) | Peptid til inducering af regenerering af væv og anvendelse deraf | |
DK2887923T3 (da) | Oftalmisk opløsning af polyoxyllipid eller polyoxylfedtsyre og behandling af øjentilstande | |
DK2717941T3 (da) | Behandling af cancer | |
DK3494972T3 (da) | Kombinationer af dolutegravir og lamivudin til behandling af HIV-infektion | |
DK2785349T3 (da) | Kombinationsbehandling af cancer | |
DK2846809T3 (da) | Behandling af myelosuppression | |
DK2903967T6 (da) | Acylaminopyrimidinderivater til behandling af virusinfektioner og andre sygdomme | |
DK2723347T3 (da) | Forebyggelse og behandling af inflammationstilstande | |
DK2747763T3 (da) | (bacterio-)chlorofyllfotosensibilisatorer til behandling af øjensygdomme og -lidelser | |
DK2658551T3 (da) | Behandling af erektil dysfunktion og andre indikationer | |
DK2854910T3 (da) | Ceramidniveauer i behandling og forebyggelse af infektioner | |
DK3060908T3 (da) | Diagnosticering og behandling af autoimmune sygdomme | |
DK2780059T3 (da) | Medicinsk anordning og fremgangsmåde til begrænsning af anvendelsen af den medicinske anordning |